These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 22761835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
    Warrington AE, Rodriguez M.
    Curr Top Microbiol Immunol; 2008; 318():213-39. PubMed ID: 18219820
    [Abstract] [Full Text] [Related]

  • 5. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K, Brück W, Kuhlmann T.
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
    Miller DJ, Rodriguez M.
    Microsc Res Tech; 1995 Oct 15; 32(3):230-45. PubMed ID: 8527857
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis.
    Hunter SF, Miller DJ, Rodriguez M.
    J Neurol Sci; 1997 Sep 10; 150(2):103-13. PubMed ID: 9268236
    [Abstract] [Full Text] [Related]

  • 8. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
    Church JS, Milich LM, Lerch JK, Popovich PG, McTigue DM.
    Glia; 2017 Jun 10; 65(6):883-899. PubMed ID: 28251686
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
    Leitzen E, Jin W, Herder V, Beineke A, Elmarabet SA, Baumgärtner W, Hansmann F.
    Int J Mol Sci; 2019 Feb 25; 20(4):. PubMed ID: 30823515
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis.
    Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M.
    J Neurosci; 1994 Oct 25; 14(10):6230-8. PubMed ID: 7931575
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
    Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH.
    Exp Neurol; 2009 Nov 25; 220(1):44-56. PubMed ID: 19616545
    [Abstract] [Full Text] [Related]

  • 12. Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
    Keough MB, Jensen SK, Yong VW.
    J Vis Exp; 2015 Mar 26; (97):. PubMed ID: 25867716
    [Abstract] [Full Text] [Related]

  • 13. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination.
    Miller DJ, Njenga MK, Murray PD, Leibowitz J, Rodriguez M.
    Int Immunol; 1996 Jan 26; 8(1):131-41. PubMed ID: 8671597
    [Abstract] [Full Text] [Related]

  • 14. Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
    Wootla B, Denic A, Watzlawik JO, Warrington AE, Rodriguez M.
    Mol Neurobiol; 2016 Oct 26; 53(8):5217-28. PubMed ID: 26409478
    [Abstract] [Full Text] [Related]

  • 15. 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.
    Feliú A, Bonilla Del Río I, Carrillo-Salinas FJ, Hernández-Torres G, Mestre L, Puente N, Ortega-Gutiérrez S, López-Rodríguez ML, Grandes P, Mecha M, Guaza C.
    J Neurosci; 2017 Aug 30; 37(35):8385-8398. PubMed ID: 28751457
    [Abstract] [Full Text] [Related]

  • 16. Immunoglobulins reactive with myelin basic protein promote CNS remyelination.
    Rodriguez M, Miller DJ, Lennon VA.
    Neurology; 1996 Feb 30; 46(2):538-45. PubMed ID: 8614528
    [Abstract] [Full Text] [Related]

  • 17. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice.
    Bieber AJ, Warrington A, Asakura K, Ciric B, Kaveri SV, Pease LR, Rodriguez M.
    Glia; 2002 Mar 01; 37(3):241-9. PubMed ID: 11857682
    [Abstract] [Full Text] [Related]

  • 18. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ, Asakura K, Rodriguez M.
    J Neurosci Res; 1995 Jun 15; 41(3):291-6. PubMed ID: 7563222
    [Abstract] [Full Text] [Related]

  • 19. Antibody-mediated remyelination: relevance to multiple sclerosis.
    Bieber A, Asakura K, Warrington A, Kaveri SV, Rodriguez M.
    Mult Scler; 2000 Oct 15; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.
    Murray PD, McGavern DB, Sathornsumetee S, Rodriguez M.
    Brain; 2001 Jul 15; 124(Pt 7):1403-16. PubMed ID: 11408335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.